XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.1

Intangible Asset (Tables)

3 Months Ended

Mar. 31, 2021

Intangible Asset

Schedule of gross carrying amount and accumulated amortization of the Nucynta Intangible Asset

​

​	​	​	​	​	​
​	As of March 31,		​	As of December 31,
​	2021		​	2020
Gross carrying amount	$	521,170	​	$	521,170
Accumulated amortization	​	(202,061)	​		(185,266)
Intangible asset, net	$	319,109	​	$	335,904

Summary of costs included in acquired asset

​

​	​	​
Acquisition consideration:	​	​
Base purchase price	$	375,000
Cash paid for inventory	​	6,030
Transaction costs	​	6,297
Reduction for 2020 cash transferred to Assertio under the prior Nucynta Commercialization Agreement(1)	​	(13,071)
Reduction for accrued royalty obligation discharged upon closing(1)	​	(1,145)
Total acquisition consideration:	$	373,111

​

(1) Represents $14,216 total reduction to the base purchase price comprising of $13,071 of cash payments transferred to Assertio under the prior Nucynta Commercialization Agreement as well as a reduction for discharged pre-acquisition accrued royalties based on sales from January 1, 2020 through closing.

​

The Company then allocated the consideration transferred to the individual assets acquired on a relative fair value basis as summarized in the table below:

​

​	​	​
Assets acquired:	​	​
Nucynta Intangible Asset	$	367,081
Inventory	​	6,030
Total consideration allocated to assets acquired:	$	373,111

Summary of the gross carrying amount, accumulated amortization, and net book value

​

​	​	​	​	​	​	​	​	​
​	​	Gross Carrying Value	​	​	Accumulated Amortization	​	​	Net Book Value
Balance as of December 31, 2019	$	154,089	​	$	(124,586)	​	$	29,503
Amortization expense through Nucynta Acquisition	​	—	​	​	(1,754)	​	​	(1,754)
Additional cost incurred from Nucynta Acquisition	​	367,081	​	​	—	​	​	367,081
Amortization expense from Nucynta Acquisition through period end	​	—	​	​	(58,926)	​	​	(58,926)
Balance as of December 31, 2020	$	521,170	​	$	(185,266)	​	$	335,904
Amortization expense	​	—	​	​	(16,795)	​	​	(16,795)
Balance as of March 31, 2021	$	521,170	​	$	(202,061)	​	$	319,109

Summary of amortization expense

​

​	​	​	​	​	​
​	Three months ended March 31,
​	​	2021		​	2020
Nucynta amortization expense included in cost of product revenues	$	16,795	​	$	10,295

Schedule of future amortization expenses

​

​	​	​
Years ended December 31,	Amortization Expense
2021	$	50,386
2022	​	67,181
2023	​	67,181
2024	​	67,181
2025	​	67,180
Remaining amortization expense:	$	319,109

X

- Definition

Summary of costs included in acquired asset.

+ References

No definition available.

+ Details

Name:	coll_SummaryOfCostsIncludedInAcquiredAsset
Namespace Prefix:	coll_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration